GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Egetis Therapeutics AB (LTS:0ABW) » Definitions » Cyclically Adjusted FCF per Share

Egetis Therapeutics AB (LTS:0ABW) Cyclically Adjusted FCF per Share : kr-1.42 (As of Mar. 2025)


View and export this data going back to 2023. Start your Free Trial

What is Egetis Therapeutics AB Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Egetis Therapeutics AB's adjusted free cash flow per share for the three months ended in Mar. 2025 was kr-0.184. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is kr-1.42 for the trailing ten years ended in Mar. 2025.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was -1.80% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 3.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Egetis Therapeutics AB was 9.60% per year. The lowest was -4.30% per year. And the median was -1.80% per year.

As of today (2025-05-27), Egetis Therapeutics AB's current stock price is kr3.14. Egetis Therapeutics AB's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was kr-1.42. Egetis Therapeutics AB's Cyclically Adjusted Price-to-FCF of today is .


Egetis Therapeutics AB Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Egetis Therapeutics AB's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Egetis Therapeutics AB Cyclically Adjusted FCF per Share Chart

Egetis Therapeutics AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - -1.58 -1.52

Egetis Therapeutics AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.59 -1.63 -1.67 -1.52 -1.42

Competitive Comparison of Egetis Therapeutics AB's Cyclically Adjusted FCF per Share

For the Biotechnology subindustry, Egetis Therapeutics AB's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Egetis Therapeutics AB's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Egetis Therapeutics AB's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Egetis Therapeutics AB's Cyclically Adjusted Price-to-FCF falls into.


;
;

Egetis Therapeutics AB Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Egetis Therapeutics AB's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=-0.184/132.8245*132.8245
=-0.184

Current CPI (Mar. 2025) = 132.8245.

Egetis Therapeutics AB Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 -0.572 99.995 -0.760
201509 -0.327 100.228 -0.433
201512 -0.285 100.276 -0.378
201603 -0.213 100.751 -0.281
201606 -0.383 101.019 -0.504
201609 -0.257 101.138 -0.338
201612 -0.251 102.022 -0.327
201703 -0.222 102.022 -0.289
201706 -0.364 102.752 -0.471
201709 -0.178 103.279 -0.229
201712 -0.843 103.793 -1.079
201803 -0.282 103.962 -0.360
201806 -0.507 104.875 -0.642
201809 -0.311 105.679 -0.391
201812 -0.374 105.912 -0.469
201903 0.499 105.886 0.626
201906 -0.488 106.742 -0.607
201909 -0.605 107.214 -0.750
201912 -0.605 107.766 -0.746
202003 -0.636 106.563 -0.793
202006 -0.578 107.498 -0.714
202009 -0.421 107.635 -0.520
202012 -0.217 108.296 -0.266
202103 -0.195 108.360 -0.239
202106 -0.212 108.928 -0.259
202109 -0.172 110.338 -0.207
202112 -0.145 112.486 -0.171
202203 -0.185 114.825 -0.214
202206 -0.178 118.384 -0.200
202209 -0.199 122.296 -0.216
202212 -0.380 126.365 -0.399
202303 -0.326 127.042 -0.341
202306 -0.251 129.407 -0.258
202309 -0.373 130.224 -0.380
202312 -0.143 131.912 -0.144
202403 -0.186 132.205 -0.187
202406 -0.188 132.716 -0.188
202409 -0.211 132.304 -0.212
202412 -0.153 132.987 -0.153
202503 -0.184 132.825 -0.184

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Egetis Therapeutics AB  (LTS:0ABW) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Egetis Therapeutics AB Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Egetis Therapeutics AB's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Egetis Therapeutics AB Business Description

Industry
Traded in Other Exchanges
Address
Grev Turegatan 11 C, Stockholm, SWE, 114 46
Egetis Therapeutics AB is an integrated pharmaceutical drug development company, focusing on projects in late-stage development for the treatment of serious rare/niche diseases with unmet medical needs in the orphan drug segment.

Egetis Therapeutics AB Headlines

No Headlines